World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ClinicalTrials.gov
Last refreshed on: 12 December 2020
Main ID:  NCT03330470
Date of registration: 17/10/2017
Prospective Registration: No
Primary sponsor: Slovak Academy of Sciences
Public title: Molecular Mediators of Physical Exercise and Carnosine Induced Effects in Patients With Preclinical and Early Stage Neurodegenerative Disease
Scientific title: Molecular Mediators of Physical Exercise and Carnosine Induced Effects in Patients With Preclinical and Early Stage Neurodegenerative Disease
Date of first enrolment: January 1, 2017
Target sample size: 100
Recruitment status: Recruiting
URL:  https://clinicaltrials.gov/show/NCT03330470
Study type:  Interventional
Study design:  Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Basic Science. Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor).  
Phase:  N/A
Countries of recruitment
Slovakia Taiwan
Contacts
Name:     Barbara Ukropcová, Assoc. Prof., MD, PhD
Address: 
Telephone: +421 2 32295 2261
Email: barbara.ukropcova@savba.sk
Affiliation: 
Name:     Barbara Ukropcová, Assoc. Prof., MD, PhD
Address: 
Telephone:
Email:
Affiliation:  Biomedical Research Center, Slovak Academy of Sciences,
Name:     Peter Valkovic, Prof., MD, PhD
Address: 
Telephone:
Email:
Affiliation:  University Hospital Bratislava, Comenius University, Bratislava,
Name:     Jozef Ukropec, DrSc, PhD
Address: 
Telephone:
Email:
Affiliation:  Biomedical Research Center, Slovak Academy of Sciences,
Name:     Barbara Ukropcová, Assoc. Prof., MD, PhD
Address: 
Telephone: +421 2 32295 2261
Email: barbara.ukropcova@savba.sk
Affiliation: 
Name:     Peter Turcáni, Prof., MD, PhD
Address: 
Telephone:
Email:
Affiliation:  University Hospital Bratislava, Comenius University, Bratislava,
Key inclusion & exclusion criteria

Inclusion Criteria:

- Signed informed consent

- Age 55 - 80 years

- Presence of Subjective Cognitive Impairment (SCI), Mild Cognitive Impairment (MCI) or
early stage of Parkinson's Disease (Hoehn-Yahr 1st-2nd stage), assessed by experienced
neurologist

Exclusion Criteria:

- Serious systemic cardiovascular, hepatic, renal disease, cancer

- Lack of compliance



Age minimum: 55 Years
Age maximum: 80 Years
Gender: All
Health Condition(s) or Problem(s) studied
Parkinson Disease
Healthy Volunteers
Mild Cognitive Impairment
Subjective Cognitive Impairment
Intervention(s)
Dietary Supplement: carnosine supplementation
Behavioral: exercise
Behavioral: stretching
Dietary Supplement: supplementation with placebo
Primary Outcome(s)
motoric functions - Berg Balance Scale [Time Frame: up to 36 months]
learning/working memory [Time Frame: up to 36 months]
glucose tolerance [Time Frame: up to 36 months]
Secondary Outcome(s)
habitual physical activity [Time Frame: up to 36 months]
physical fitness [Time Frame: up to 36 months]
Secondary ID(s)
15-0253
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
Comenius University
National Cheng Kung University
University Hospital Bratislava
Ethics review
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history